BR9507517A - Benzocycloalkylazotethione derivatives - Google Patents

Benzocycloalkylazotethione derivatives

Info

Publication number
BR9507517A
BR9507517A BR9507517A BR9507517A BR9507517A BR 9507517 A BR9507517 A BR 9507517A BR 9507517 A BR9507517 A BR 9507517A BR 9507517 A BR9507517 A BR 9507517A BR 9507517 A BR9507517 A BR 9507517A
Authority
BR
Brazil
Prior art keywords
thioxo
dihydro
benzocycloalkylazolethione
triazol
substituents
Prior art date
Application number
BR9507517A
Other languages
Portuguese (pt)
Inventor
Gregory R Martinez
David R Repke
Philip J Teitelbaum
Keith A M Walker
Owen W Gooding
Roger L Whiting
Rekxa P Bansal
Alexander V Muehldorf
Counde O'yang
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27398461&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9507517(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/233,655 external-priority patent/US5438150A/en
Priority claimed from US08/403,209 external-priority patent/US5538988A/en
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of BR9507517A publication Critical patent/BR9507517A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C07D233/36—One oxygen atom with hydrocarbon radicals, substituted by nitrogen atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/42—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Abstract

The present invention relates to novel benzocycloalkylazolethione compounds of formula (I) in which n is 0, 1 or 2; t is 0, 1, 2 or 3; R<1> is independently halo, hydroxy or (C1-4)alkyloxy; and R<2> is attached to the alpha , beta or gamma -position and is a group selected from formulae (a), (b) and (c) which are dopamine beta -hydroxylase inhibitors in which the benzocycloalkyl portion of the compound is selected from indanyl, 1,2,3,4-tetrahydronaphthalenyl and 6,7,8,9-tetrahydro-5H-benzocycloheptenyl (in which the benzo is optionally substituted with one to three substituents) and the azolethione portion of the compound is selected from 2-thioxo-2,3-dihydro-1H-imidazol-3-yl, 5-thioxo-4,5-dihydro-1H-[1,2,4]triazol-4-yl and 5-thioxo-4,5-dihydro-1H-[1,2,4]triazol-1-yl (each optionally substituted with one to three substituents); and the prodrugs, pharmaceutically acceptable salts, individual isomers and mixtures of isomers and the methods of using and preparing such benzocycloalkylazolethione compounds.
BR9507517A 1994-04-26 1995-04-25 Benzocycloalkylazotethione derivatives BR9507517A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US23383594A 1994-04-26 1994-04-26
US08/233,655 US5438150A (en) 1994-04-26 1994-04-26 Process for making 1-benzocycloalkyl-1,3-dihydroimidazole-2-thione derivatives
US08/403,209 US5538988A (en) 1994-04-26 1995-03-17 Benzocycloalkylazolethione derivatives
PCT/US1995/004783 WO1995029165A2 (en) 1994-04-26 1995-04-25 Benzocycloalkylaz0lethione derivatives as dopamin beta-hydroxylase inhibitors

Publications (1)

Publication Number Publication Date
BR9507517A true BR9507517A (en) 1997-09-16

Family

ID=27398461

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9507517A BR9507517A (en) 1994-04-26 1995-04-25 Benzocycloalkylazotethione derivatives

Country Status (21)

Country Link
EP (1) EP0757677B1 (en)
JP (1) JPH09512269A (en)
CN (1) CN1113874C (en)
AT (1) ATE243199T1 (en)
AU (1) AU687192B2 (en)
BR (1) BR9507517A (en)
CA (1) CA2188748A1 (en)
CZ (1) CZ290082B6 (en)
DE (1) DE69531102T2 (en)
DK (1) DK0757677T3 (en)
ES (1) ES2201104T3 (en)
FI (1) FI964312A (en)
HU (1) HUT76295A (en)
IL (1) IL113480A (en)
MX (1) MX9605145A (en)
NO (1) NO311720B1 (en)
NZ (1) NZ284356A (en)
PL (1) PL185959B1 (en)
PT (1) PT757677E (en)
RU (1) RU2145321C1 (en)
WO (1) WO1995029165A2 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2201944B1 (en) 1997-11-21 2012-05-23 Purdue Neuroscience Company Use of substituted 2-aminoacetamides for treating, preventing or ameliorating manic depression
AU2298399A (en) * 1998-02-06 1999-08-23 Yoshitomi Pharmaceutical Industries, Ltd. Novel azapeptide type hydroxamic acid derivatives
JP4978762B2 (en) * 2001-03-30 2012-07-18 Ｄｉｃ株式会社 Method for producing cyclohex-3-en-1-ol derivative
GB2393958A (en) * 2002-10-11 2004-04-14 Portela & Ca Sa Peripherally-selective imidazole inhibitors of dopamine-beta-hydroxylase
US7125904B2 (en) * 2002-10-11 2006-10-24 Portela & C.A., S.A. Peripherally-selective inhibitors of dopamine-β-hydroxylase and method of their preparation
GB0600709D0 (en) * 2006-01-13 2006-02-22 Portela & Ca Sa Drug combinations
RU2009126571A (en) 2006-12-12 2011-01-20 Биал-Портела Энд Ка, С.А. (Pt) CATALYTIC METHOD FOR ASYMMETRIC HYDROGENIZATION
US20100093817A1 (en) * 2007-02-01 2010-04-15 Bial - Portela & Ca S.A. Compounds
EP1977646A1 (en) * 2007-04-03 2008-10-08 Bayer CropScience AG Insecticidal hydroxyethyl thlourea derivatives
GB0708818D0 (en) * 2007-05-08 2007-06-13 Portela & Ca Sa Compounds
GB0709695D0 (en) * 2007-05-21 2007-06-27 Portela & Ca Sa Process
TW200927740A (en) * 2007-11-13 2009-07-01 Bial Portela & Ca Sa Process
EP2726454B1 (en) 2011-06-29 2018-01-24 Bial-Portela & CA, S.A. Process
TR201815850T4 (en) * 2012-11-14 2018-11-21 Bial Portela & Ca Sa 1,3-dihydroimidazol-2-thion derivatives for use in the treatment of pulmonary arterial hypertension and lung injury.
EP3490554B1 (en) * 2016-07-28 2023-07-05 Jiangsu Yahong Meditech Co., Ltd. Uses of dopamine beta-hydroxylase (dbh) inhibitors for the treatment of cancer
JOP20190050A1 (en) 2016-09-23 2019-03-20 Bial Portela & C? S A Blood-brain barrier-penetrant dopamine-?-hydroxylase inhibitors
US11434242B2 (en) 2017-12-04 2022-09-06 Bial—Portela & Ca, S.A. Dopamine-b-hydroxylase inhibitors
GB201908044D0 (en) 2019-06-05 2019-07-17 Bial Portela & Ca Sa Dopamine-B-Hydroxylase inhibitors
MX2023008573A (en) 2021-01-26 2023-08-08 Jiangsu Yahong Meditech Co Ltd Pathway modulator, pharmaceutical composition having same, use thereof, and therapeutic method using same.
CN113527108B (en) * 2021-09-16 2022-10-25 斯芬克司药物研发（天津）股份有限公司 Process for preparing optically pure 5, 7-difluoro-1, 2,3, 4-tetrahydronaphthalen-2-amine and salts thereof
CN114920906B (en) * 2022-05-23 2023-03-21 华南理工大学 Polyurethane containing imidazolethione unit and preparation method and application thereof
WO2024056079A1 (en) * 2022-09-16 2024-03-21 江苏亚虹医药科技股份有限公司 Polymorphic form of nepicastat acid addition salt, preparation method therefor and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3485917A (en) * 1966-04-14 1969-12-23 Janssen Pharmaceutica Nv Composition and method for combating fungus with imidazole carboxylates
GB8516573D0 (en) * 1985-07-01 1985-08-07 Janssen Pharmaceuticaa Nv Controlling weeds
EP0277384A3 (en) * 1986-12-24 1990-05-23 Janssen Pharmaceutica N.V. 1h-imidazole-5-carboxylic acid derivatives

Also Published As

Publication number Publication date
WO1995029165A3 (en) 1995-12-07
MX9605145A (en) 1997-12-31
NO311720B1 (en) 2002-01-14
IL113480A (en) 2000-06-29
RU2145321C1 (en) 2000-02-10
HUT76295A (en) 1997-07-28
DE69531102D1 (en) 2003-07-24
FI964312A (en) 1996-12-20
DK0757677T3 (en) 2003-10-13
FI964312A0 (en) 1996-10-25
AU2294795A (en) 1995-11-16
WO1995029165A2 (en) 1995-11-02
NO964552D0 (en) 1996-10-25
PL316856A1 (en) 1997-02-17
PT757677E (en) 2003-11-28
ES2201104T3 (en) 2004-03-16
CZ290082B6 (en) 2002-05-15
NZ284356A (en) 1997-12-19
EP0757677A1 (en) 1997-02-12
DE69531102T2 (en) 2004-04-29
PL185959B1 (en) 2003-09-30
CZ310996A3 (en) 1997-06-11
JPH09512269A (en) 1997-12-09
CN1113874C (en) 2003-07-09
CN1151735A (en) 1997-06-11
HU9602946D0 (en) 1996-12-30
ATE243199T1 (en) 2003-07-15
CA2188748A1 (en) 1995-11-02
AU687192B2 (en) 1998-02-19
IL113480A0 (en) 1995-07-31
EP0757677B1 (en) 2003-06-18
NO964552L (en) 1996-12-27

Similar Documents

Publication Publication Date Title
PT757677E (en) BENZOCYCLOHEXYLIMIDAZOLETION DERIVATIVES
ES2160949T3 (en) DERIVATIVES OF PHENYLENE-SULFONAMIDE REPLACED IN META.
DE69705300T2 (en) CYCLOPROPYLALKANSÄUREDERIVATE
KR950017957A (en) Preparation and intermediates of 3, 4, 4-trisubstituted-piperidinyl-N-alkylcarboxylates
IL99759A (en) Mono-fluorinated derivatives of n-propargyl-1-aminoindan, their preparation and pharmaceutical compositions containing them
CA2113229A1 (en) Anti-fibrotic quinazolinone-containing compositions and methods for the use thereof
ES2164763T3 (en) COMPOSITIONS FOR CLEARING THE SKIN.
EP1019045A4 (en) Antithrombotic agents
IL133627A0 (en) Antithrombotic agents
ES2150489T3 (en) 1-AMIDINOFENIL-PIRROLIDONAS, -PIPERIDINONAS, -AZETINONAS AS INHIBITORS OF THE AGGREGATION OF PLATELETS.
BR9908545A (en) Piperidine derivative, process for preparing it, compound, process for preparing it, and pharmaceutical composition
CA2073686A1 (en) N,n&#39;-dihaloimidazolidin-4-ones
ATE109787T1 (en) ANTHRACYCLINE ANALOGUES CONTAINING LATENT ALKYLATION SUBSTITUENTS.
CO5070569A1 (en) COMPOUND OF AMINOAZOL OR A PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME AND MEDICINAL PRODUCT CONTAINING THEM
ES2108422T3 (en) SYNERGIC COMBINATIONS OF ANTISOLAR PRODUCTS AND COSMETIC AND DERMATOLOGICAL COMPOSITIONS THAT CONTAIN THEM.
MX9805023A (en) 1-methylcarbapenem derivatives.
UA27108A1 (en) Anthracycline glycosides and their pharmaceutically acceptable acid-additive salts, method of their synthesis, diiodointermediate compound and method of its synthesis
EP0645382A4 (en) Coumarin derivative and use thereof.
HU9503775D0 (en) Benzene derivative useful for ischemic diseases
AR004949A1 (en) DERIVATIVES OF BENZOIL-4-PIRAZOL, PROCEDURE TO OBTAIN THEM, CONTAINING HERBICIDAL COMPOSITIONS AND PROCEDURES FOR COMBATING UNDESIRABLE PLANTS.
RU94044457A (en) Use of benzthiophenes for hirsutism and alopecia inhibition
CA2052020A1 (en) Pradimicin derivatives
NO20004685L (en) New connections
DE69528984D1 (en) INHIBITION OF LEUKOTRIA BIOSYNTHESIS BY URINE DERIVATIVES
ES8605819A1 (en) Antiviral nucleoside derivatives

Legal Events

Date Code Title Description
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
HJEG Technical examination (opinion): technical examination (opinion) related to article 229 of industrial property law
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B25A Requested transfer of rights approved

Free format text: SYNTEX (U.S.A.) LLC (US)

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B24C Patent annual fee: request for for restoration

Free format text: REFERENTE A 11A,12A,13A,14A,15A E 16A ANUIDADES

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE AS 16A, 17A, 18A, 19A E 20A ANUIDADES. PAGAR RESTAURACAO.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.